BC Platforms And Blueprint Genetics Partner To Enable Precision Medicine In Rare Diseases

Pixabay License | Source: Gerd Altmann , no changes made.
Advertisement

BC Platforms, a world leader in genomic data management and analytics, has formed a collaboration with Blueprint Genetics, a leader in the field of clinical genetic testing, to develop new data driven services for hospitals and the life sciences industry.

BC Platforms, founded in 1997 from an MIT Whitehead project spinoff, is in the business of powerful genomic data management and analysis solutions. The company operates a Global Network of Biobanks known as BCRQUEST.COM, a streamlined solution for secure data sharing, analytics and governance, enabling greater collaboration for scientific innovation.

BC Platforms has global operations with its headquarters in Basel, Switzerland, research and development in Helsinki, Finland, and sales and marketing in London, Boston, and Vancouver. The company’s vision is to build the world’s leading analytics platform for healthcare and industry by 2020.

Blueprint Genetics is one of the fastest growing genetic testing businesses globally in the field of clinical genetic testing of rare inherited diseases. With a patient centered mindset, the company was founded in 2012 and has since been on a mission to bring world-class genetic knowledge to mainstream healthcare with four guiding principles: innovation, transparency, quality and accessibility. The company is based in Helsinki, Finland and Seattle, USA, with a customer base spanning over 70 countries.

The collaboration combines Blueprint Genetics’ excellence in clinical genetic testing with BC Platforms’ high performing data management platform to facilitate the utilization of large amounts of genetic data in day-to-day patient care, clinical studies and industry initiatives such as sponsored testing programs. This all-encompassing approach will be supported by a secure and fully compliant system that maintains privacy while supporting openness and collaboration.

The second element of this project will be the creation of an advanced platform for the provision of genetic data and providing a scalable environment for data storage and analysis. This technology is supported by high-quality, curated data sets and health-related information. Such a wide breadth of organized, harmonized data will support efficient genetic testing results and ultimately improve patient care. Essentially, creating this seamless platform for integrated genetic testing and clinical data applications will serve to enable precision medicine by combining technical expertise and unique approaches to clinical genomics.

“We are delighted to be working with Blueprint Genetics, who are rapidly establishing themselves as leaders in the clinical genetic testing field for rare diseases. We believe that together we can provide a highly competitive platform and a one-stop shop for genetic testing and data management to help patients suffering from rare inherited diseases.” – Tero Silvola, CEO, BC Platforms

“I am very excited about this collaboration. Linking our high-quality genetic testing with BC Platforms data management capabilities allows us to improve patient outcomes, reduce operating costs in healthcare organizations and speed up the time-to-discovery.” Tommi Lehtonen, CEO, Blueprint Genetics

Source

  1. https://www.prnewswire.com/news-releases/bc-platforms-partners-with-blueprint-genetics-to-provide-center-of-excellence-for-data-driven-testing-services-in-rare-diseases-300940428.html

David is a consultant/medical writer for a number of ongoing healthcare initiatives including for Athla LLC/ HealthLabs, a discovery automation company for Big Data leveraging Big Compute. He has a number of years experience in academic R&D and healthcare related projects including the fields of oncology and immunotherapy.